PNC Financial Services Group’s Olema Pharmaceuticals OLMA Stock Holding History

PNC Financial Services Group’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.14K	Buy	711 +131	+23%	+$1.43K	﹤0.01%	4418
2026 Q2	$7.26K	Buy	580 +29	+5%	+$388	﹤0.01%	4240
2026 Q1	$8.21K	Hold	551	–	–	﹤0.01%	4039
2025 Q4	$13.8K	Sell	551 -166	-23%	-$2.95K	﹤0.01%	3823
2025 Q3	$7.02K	Buy	717 +1	+0.1%	+$6	﹤0.01%	4077
2025 Q2	$3.05K	Sell	716 -419	-37%	-$1.87K	﹤0.01%	4290
2025 Q1	$4.27K	Buy	1,135 +6	+0.5%	+$30	﹤0.01%	4118
2024 Q4	$6.58K	Sell	1,129 -153	-12%	-$1.53K	﹤0.01%	3950
2024 Q3	$15.3K	Sell	1,282 -132	-9%	-$1.69K	﹤0.01%	3634
2024 Q2	$15.3K	Buy	+1,414	New	+$15.3K	﹤0.01%	3605
2022 Q2	–	Sell	-1,202	Closed	-$5K	–	4651
2022 Q1	$5K	Buy	+1,202	New	+$6.62K	﹤0.01%	4006

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

SEB Asset Management Stockholm $27B AUM

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

PNC Financial Services Group's OLMA Position: Q3 2026 in Review

PNC Financial Services Group increased its Olema Pharmaceuticals (OLMA) stake by 23% in Q3 2026, buying an estimated $1.43K and bringing the position to 711 shares worth $6.14K. The position accounts for ﹤0.01% of the portfolio, ranked #4418.

PNC Financial Services Group first reported a position in OLMA in Q1 2022 and has held it in 11 quarters since. The position peaked at $15.3K in Q3 2024. 91 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.

PNC Financial Services Group held 711 shares of Olema Pharmaceuticals worth $6.14K as of Q3 2026.
PNC Financial Services Group bought 131 Olema Pharmaceuticals shares in Q3 2026, an estimated $1.43K.
Olema Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4418 holding.
PNC Financial Services Group first reported a position in Olema Pharmaceuticals in Q1 2022 and has held it in 11 quarters since.
PNC Financial Services Group's Olema Pharmaceuticals position peaked at $15.3K in Q3 2024.
91 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.